Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Oncotarget|October 6, 2017
Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2BJiangeng Yang, Yuchen Liu, Anbang He, et al.International Journal of Biological Sciences|February 17, 2022
Ascorbic acid induced TET2 enzyme activation enhances cancer immunotherapy efficacy in renal cell carcinomaDing Peng, Anbang He, Shiming He, et al.Aging|November 22, 2020
Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancerYucai Wu, Lei Zhang, Shiming He, et al.Oncotarget|October 8, 2016
Role of long noncoding RNA UCA1 as a common molecular marker for lymph node metastasis and prognosis in various cancers: a meta-analysisAnbang He, Rong Hu, Zhicong Chen, et al.Frontiers in Genetics|September 28, 2020
Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder CancerYucai Wu, Yi Liu, Anbang He, et al.Cancer Biomarkers : Section a of Disease Markers|December 12, 2017
Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancerXinhui Liao, Jieqing Chen, Yuchen Liu, et al.Oncotargets and Therapy|May 23, 2019
High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese centerYifan Li, Dong Fang, Zhengqing Bao, et al.Ebiomedicine|July 25, 2018
Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated AnalysisZhicong Chen, Yonghao Zhan, Jieshan Chi, et al.Molecular Cancer|February 6, 2020
Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2Yonghao Zhan, Zhicong Chen, Shiming He, et al.Oncotarget|April 28, 2017
Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancerJunhao Lin, Yonghao Zhan, Yuchen Liu, et al.Pageof 5